Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that the European Patent Office (EPO) has granted its European Patent Application Number ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE